Today: 14 June 2026

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Intuit (INTU) Stock Rises on $100M+ OpenAI Deal to Bring TurboTax and QuickBooks Into ChatGPT

Intuit (INTU) Stock Rises on $100M+ OpenAI Deal to Bring TurboTax and QuickBooks Into ChatGPT

Intuit announced a multi-year partnership with OpenAI, signing a contract worth over $100 million to integrate OpenAI’s models into its AI platform and products. TurboTax, QuickBooks, Credit Karma, and Mailchimp will be available as apps inside ChatGPT. Intuit shares rose about 1% to $652.98 after the news. Large investors, including Nomura Asset Management, increased their stakes following the announcement.
Temu Owner PDD Holdings Beats Profit Forecasts but Warns of Slower Growth as Stock Slides on Q3 2025 Results

Temu Owner PDD Holdings Beats Profit Forecasts but Warns of Slower Growth as Stock Slides on Q3 2025 Results

PDD Holdings reported Q3 2025 revenue of RMB 108.28 billion, up 9% year over year, marking a slowdown from previous growth rates. Net income rose 17% to RMB 29.33 billion, beating analyst forecasts. Shares fell as investors reacted to cooling revenue growth amid fierce competition from Alibaba and JD.com. Operating cash flow jumped to RMB 45.66 billion from RMB 27.52 billion a year earlier.
Can-Fite BioPharma (CANF) Soars on 9-Year Liver Cancer Survival Breakthrough with Namodenoson – November 18, 2025

Can-Fite BioPharma (CANF) Soars on 9-Year Liver Cancer Survival Breakthrough with Namodenoson – November 18, 2025

Can-Fite BioPharma shares surged over 30% Tuesday after reporting a patient with advanced hepatocellular carcinoma remained cancer-free for nine years on its drug Namodenoson. The company also began enrolling patients in a pivotal Phase III trial for the treatment in Israel, Europe, and the U.S. Namodenoson holds Orphan Drug and Fast Track designations.
Baidu (BIDU) Q3 2025 Earnings: Revenue Falls 7% as AI Cloud and Robotaxis Power a Big EPS Beat

Baidu (BIDU) Q3 2025 Earnings: Revenue Falls 7% as AI Cloud and Robotaxis Power a Big EPS Beat

Baidu reported Q3 2025 revenue of RMB 31.2 billion, down 7% year over year but above analyst estimates. The company posted a net loss of RMB 11.2 billion, mainly due to a RMB 16.2 billion impairment. Non-GAAP net income reached RMB 3.8 billion, beating expectations. AI-powered business revenue surged over 50% to nearly RMB 10 billion, while online ad revenue fell 18%.
Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Medtronic reported Q2 FY26 revenue of $8.96 billion, up 6.6% year over year, and non-GAAP EPS of $1.36, beating Wall Street estimates. Shares rose 4–5% intraday. Cardiac ablation revenue jumped 71% globally, with 128% growth in the U.S. The company raised its full-year outlook after its fourth straight quarter of beating consensus EPS.
VOO Today: Vanguard S&P 500 ETF slips as Wall Street braces for Nvidia earnings and a heavy data slate — Nov. 18, 2025

VOO Today: Vanguard S&P 500 ETF slips as Wall Street braces for Nvidia earnings and a heavy data slate — Nov. 18, 2025

The Vanguard S&P 500 ETF (VOO) traded near $604.85, down about 1.2% intraday Tuesday, after a tech-led selloff pulled the S&P 500 lower by 0.9% on Monday. Traders are watching for Nvidia’s Q3 FY26 earnings Wednesday, with options signaling a possible sharp move. Fund flows into VOO remain strong, with about $6.6 billion in net inflows reported over five days.
VTI vs. SCHB on November 18, 2025: What’s Moving Vanguard’s Total‑Market ETF Today—and Which “Total Stock” Fund Has the Edge?

VTI vs. SCHB on November 18, 2025: What’s Moving Vanguard’s Total‑Market ETF Today—and Which “Total Stock” Fund Has the Edge?

VTI fell 1.04% Monday and is down 2.11% over five days as tech-valuation concerns and anticipation of Nvidia earnings drove U.S. futures and benchmarks lower. The ETF saw $170 million in net inflows over five sessions, with Nvidia, Apple, and Microsoft as top holdings. SCHB completed a 3-for-1 split on Oct. 10, 2024. Both VTI and SCHB charge 0.03% but track different indexes and differ in holdings and assets.
Emirates turns the screws on Boeing with $38B 777X order as it snubs Airbus A350‑1000 over engine concerns — Dubai Airshow 2025

Emirates turns the screws on Boeing with $38B 777X order as it snubs Airbus A350‑1000 over engine concerns — Dubai Airshow 2025

Emirates finalized a $38 billion order for 65 Boeing 777-9s at the Dubai Airshow, raising its 777X backlog to 270 jets with first deliveries from Q2 2027. The airline ruled out new Airbus A350-1000 purchases until Rolls-Royce upgrades engines, expected from 2028. Emirates also supports Boeing’s study of a larger 777-10 and may convert part of its order.
Stock Market Today (Nov. 18, 2025): Nasdaq slides as AI trade stumbles; Tesla, Palantir, SMCI pace tech losses ahead of Nvidia earnings; Disney ends YouTube TV blackout

Stock Market Today (Nov. 18, 2025): Nasdaq slides as AI trade stumbles; Tesla, Palantir, SMCI pace tech losses ahead of Nvidia earnings; Disney ends YouTube TV blackout

U.S. stocks fell for a fourth straight session Tuesday, with the Dow down nearly 500 points intraday and the Nasdaq off up to 1.5% as investors sold AI-linked shares and weighed fading odds of a December Fed rate cut. Tesla, Palantir, and Super Micro Computer posted notable declines. Nvidia’s earnings report Wednesday looms, with options markets bracing for a 7% swing. A Cloudflare outage briefly disrupted major tech services, adding to sector jitters.
Microsoft (MSFT) and Amazon (AMZN) Downgraded to Neutral by Rothschild & Co Redburn on AI Capex Concerns — Stocks Slip on Nov. 18, 2025

Microsoft (MSFT) and Amazon (AMZN) Downgraded to Neutral by Rothschild & Co Redburn on AI Capex Concerns — Stocks Slip on Nov. 18, 2025

Rothschild & Co Redburn downgraded Microsoft and Amazon to Neutral from Buy on Tuesday, citing concerns over capital intensity and slower AI monetization. Analyst Alex Haissl cut Microsoft’s price target to $500 and left Amazon’s at $250. Both stocks fell over 3% intraday, underperforming the market. The move contrasts with widespread bullish sentiment among Wall Street peers.
Stock Market Today, 18 November 2025: Dow Extends Slide as AI Bubble Fears Grow and Home Depot Earnings Rattle Wall Street

Stock Market Today, 18 November 2025: Dow Extends Slide as AI Bubble Fears Grow and Home Depot Earnings Rattle Wall Street

U.S. stocks fell Tuesday, with the Dow down nearly 1%, the S&P 500 off 0.5%, and the Nasdaq 100 slipping 0.9% by late morning. Renewed fears of an AI bubble ahead of Nvidia’s earnings and a weaker outlook from Home Depot fueled the decline. All three indexes hovered near one-month lows, extending Monday’s losses. Home Depot shares dropped over 3% after missing profit estimates.
Harvard’s $443 Million Bitcoin Bet Signals a New Era for University Endowments — Even as BTC Slides Below $90,000

Harvard’s $443 Million Bitcoin Bet Signals a New Era for University Endowments — Even as BTC Slides Below $90,000

Harvard University’s endowment has tripled its stake in BlackRock’s iShares Bitcoin Trust to about $443 million, making Bitcoin its largest disclosed U.S. holding. Emory University and Abu Dhabi’s Al Warda Investments have also increased Bitcoin ETF exposure. Bitcoin ETFs saw over $2.3 billion in outflows in November as Bitcoin fell below $90,000.
18 November 2025
Google Vids Expands AI Access: Free Gemini Tools for Gmail Users and New Veo 3.1 ‘Ingredients‑to‑Video’ Integration

Google Vids Expands AI Access: Free Gemini Tools for Gmail Users and New Veo 3.1 ‘Ingredients‑to‑Video’ Integration

On November 18, 2025, Google made Gemini AI video editing features in Google Vids free for all Gmail users. Workspace and Google AI subscribers also gain access to Veo 3.1’s “ingredients-to-video” tool, which turns up to three images and a prompt into short video clips. Some advanced features, like text-to-video and AI avatars, remain paid.
18 November 2025
Chinese Hackers, Anthropic’s Claude and the First AI‑Orchestrated Cyber‑Espionage Campaign: What We Know as of November 18, 2025

Chinese Hackers, Anthropic’s Claude and the First AI‑Orchestrated Cyber‑Espionage Campaign: What We Know as of November 18, 2025

Anthropic confirmed a Chinese state-backed group used its Claude AI tool to automate a cyber-espionage campaign in September 2025, targeting about 30 organizations globally. The AI handled up to 90% of operational tasks, with humans providing only high-level oversight. Several intrusions succeeded, compromising sensitive data at major firms and government agencies. Anthropic banned accounts and notified affected parties.
Microsoft Azure Blocks Record 15.7 Tbps DDoS Attack as Kenyan Government Websites Recover and ‘EVALUSION’ Malware Campaign Emerges

Microsoft Azure Blocks Record 15.7 Tbps DDoS Attack as Kenyan Government Websites Recover and ‘EVALUSION’ Malware Campaign Emerges

Microsoft said its Azure cloud blocked a record 15.72 Tbps DDoS attack on October 24, driven by the Aisuru IoT botnet. Kenya restored government websites after extremist defacement on November 17. Researchers reported a new EVALUSION malware campaign using phishing to deploy Amatera Stealer and NetSupport RAT.
Olema Pharmaceuticals (OLMA) Soars Over 200% After Roche Breast Cancer Trial Win — What It Means for Palazestrant and Investors on November 18, 2025

Olema Pharmaceuticals (OLMA) Soars Over 200% After Roche Breast Cancer Trial Win — What It Means for Palazestrant and Investors on November 18, 2025

Olema Pharmaceuticals shares surged as much as 220% in pre-market trading on November 18 after Roche announced a Phase 3 win for its oral SERD giredestrant in early-stage breast cancer. The spike was driven by investor read-through to Olema’s similar drug palazestrant, not new Olema data. Volume hit 13.4 million shares, far above average. Shares later retreated toward the low-$20s during regular trading.
U.S. Factory Orders Rebound 1.4% as Industrial Production Data Goes Dark: Key Economic Events on November 18, 2025

U.S. Factory Orders Rebound 1.4% as Industrial Production Data Goes Dark: Key Economic Events on November 18, 2025

U.S. factory orders rose 1.4% in August, rebounding from a 1.3% drop in July, Census Bureau data showed Tuesday after delays from the government shutdown. Key economic reports, including industrial production and import/export price indexes, remained unavailable. The NAHB Housing Market Index held at 37 in November, signaling continued weakness in homebuilder sentiment.
18 November 2025
San Antonio Power Outages, Traffic Jams and Winter Grid Readiness: What CPS Energy Customers Need to Know on November 18, 2025

San Antonio Power Outages, Traffic Jams and Winter Grid Readiness: What CPS Energy Customers Need to Know on November 18, 2025

A vehicle struck power lines near South Flores Street early Monday, knocking out electricity for about 30 CPS Energy customers and closing part of the road. Crews worked through the morning to restore service and clear debris. The outage came hours after CPS officials told their board the utility has added nearly 3,000 megawatts of winter capacity since last year. No injuries were reported.
18 November 2025
Synovus Financial (SNV) Stock: Q3 Earnings Beat, Barclays Price Target Hike and Fresh Institutional Buying – November 18, 2025

Synovus Financial (SNV) Stock: Q3 Earnings Beat, Barclays Price Target Hike and Fresh Institutional Buying – November 18, 2025

Synovus Financial reported Q3 adjusted EPS of $1.46, beating estimates by $0.10, with revenue up 9% to about $612 million. Shares have risen 4.5% since October’s earnings release, trading near $44 as of mid-day November 18. Barclays raised its price target to $65, and new 13F filings show increased institutional ownership. Non-performing loans and charge-offs fell sharply in the quarter.
18 November 2025
CrowdStrike Stock: Rosenblatt Hikes Price Target to $630 as AI Security Alliances and Google Recognition Ignite Wall Street

CrowdStrike Stock: Rosenblatt Hikes Price Target to $630 as AI Security Alliances and Google Recognition Ignite Wall Street

Rosenblatt raised its price target for CrowdStrike to $630 on November 18, 2025, citing strong AI security partnerships, including new alliances with Google Cloud. Capital One and Berenberg also lifted their targets to $599 and $600, respectively. Recent analyst upgrades have pushed CrowdStrike’s one-year target range to $540–$630.
1 26 27 28 29 30 146

Stock Market Today

  • Japan Exchange Group Stock Valuation Rises on AI Transcript Partnership
    June 14, 2026, 12:52 AM EDT. Japan Exchange Group (TSE:8697) gains market focus following a partnership with RavenPack to integrate AI-processed earnings transcripts. The stock showed a strong 30-day price return of 17.53% and a 1-year total shareholder return of 41.84%, reflecting optimism around its role in Japanese market infrastructure. Trading at a price-to-earnings (P/E) ratio of 27.6x, it is notably higher than the industry average of 11.2x, suggesting the market prices in expected growth or resilience. However, discounted cash flow analysis indicates potential overvaluation. Key risks include AI adoption setbacks and regulatory challenges impacting trading volumes and fee income. Investors should weigh these valuation signals and monitor ongoing developments in AI data usage for informed decision-making.

Latest articles

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

14 June 2026
Kraft Heinz closed up 0.70% at $24.39, outpacing the S&P 500, as investors weighed its 6.6% dividend yield against falling organic sales, lower adjusted earnings, and cautious analyst targets; the next earnings update is seen as the key test for whether $600 million in marketing and R&D can revive growth and support the stock’s rebound.
Go toTop